Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel R Payer

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Haematologica|September 29, 2018
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaNeus Giménez, Alejandra Martínez-Trillos, Arnau Montraveta, et al.
Leukemia & Lymphoma|November 9, 2017
The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemiaAlejandra Martínez-Trillos, Magda Pinyol, Julio Delgado, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Haematologica|September 29, 2018
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaNeus Giménez, Alejandra Martínez-Trillos, Arnau Montraveta, et al.
Leukemia & Lymphoma|November 9, 2017
The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemiaAlejandra Martínez-Trillos, Magda Pinyol, Julio Delgado, et al.
Pageof 2